IN2014DN09830A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN09830A IN2014DN09830A IN9830DEN2014A IN2014DN09830A IN 2014DN09830 A IN2014DN09830 A IN 2014DN09830A IN 9830DEN2014 A IN9830DEN2014 A IN 9830DEN2014A IN 2014DN09830 A IN2014DN09830 A IN 2014DN09830A
- Authority
- IN
- India
- Prior art keywords
- formula
- vivo
- exhibits
- correction
- enabling
- Prior art date
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- 239000008103 glucose Substances 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 0 CC1=C(CCC[C@]2(CC*)[C@](CCCCC3C(CC4CC4)C3)CCC2)CCC1 Chemical compound CC1=C(CCC[C@]2(CC*)[C@](CCCCC3C(CC4CC4)C3)CCC2)CCC1 0.000 description 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/10—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Optics & Photonics (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1207392.0A GB201207392D0 (en) | 2012-04-27 | 2012-04-27 | Novel compounds |
PCT/GB2013/051079 WO2013160701A1 (en) | 2012-04-27 | 2013-04-26 | Anthracenyl - tetralactam macrocycles and their use in detecting a target saccharide |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN09830A true IN2014DN09830A (enrdf_load_stackoverflow) | 2015-08-07 |
Family
ID=46330449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN9830DEN2014 IN2014DN09830A (enrdf_load_stackoverflow) | 2012-04-27 | 2013-04-26 |
Country Status (9)
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201207392D0 (en) | 2012-04-27 | 2012-06-13 | Univ Bristol | Novel compounds |
JP7427449B2 (ja) * | 2017-03-15 | 2024-02-05 | ノヴォ・ノルディスク・リサーチ・センター・オックスフォード・リミテッド | 大員環化合物 |
JP7439062B2 (ja) * | 2018-09-19 | 2024-02-27 | ノヴォ・ノルディスク・リサーチ・センター・オックスフォード・リミテッド | グルコース感受性インスリンおよびその使用 |
US11410752B2 (en) | 2019-07-30 | 2022-08-09 | Emd Millipore Corporation | Method of synthesizing chemical compounds |
RU2752711C2 (ru) * | 2019-11-18 | 2021-07-30 | Общество с ограниченной ответственностью «Лаборатория межклеточных технологий «Интерсел Рэнд» (ООО «Интерсел Рэнд») | Способ и устройство для спектроскопии живой ткани |
KR20230127067A (ko) * | 2022-02-24 | 2023-08-31 | 삼성에스디아이 주식회사 | 코어-쉘 염료, 이를 포함하는 근적외선 흡수성 수지 조성물 및 근적외선 흡수 필름 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6815901A (en) * | 2000-06-02 | 2001-12-17 | Zycos Inc | Delivery systems for bioactive agents |
JP2003073399A (ja) * | 2001-08-31 | 2003-03-12 | Japan Science & Technology Corp | 発蛍光性修飾タンパク質 |
US7179616B1 (en) | 2002-10-07 | 2007-02-20 | University Of Notre Dame Du Lac | Method for detecting phosphatidylserine on the surface of cells |
US8642014B2 (en) * | 2007-01-30 | 2014-02-04 | Seta Biomedicals, Llc | Luminescent compounds |
WO2011059457A1 (en) | 2009-11-16 | 2011-05-19 | University Of Notre Dame Du Lac | High performance luminescent compounds |
WO2011087521A1 (en) * | 2010-01-13 | 2011-07-21 | University Of Notre Dame Du Lac | Chemiluminescent dyes and dye-stained particles |
GB201207392D0 (en) | 2012-04-27 | 2012-06-13 | Univ Bristol | Novel compounds |
-
2012
- 2012-04-27 GB GBGB1207392.0A patent/GB201207392D0/en not_active Ceased
-
2013
- 2013-04-26 EP EP13727309.0A patent/EP2855439B1/en not_active Not-in-force
- 2013-04-26 WO PCT/GB2013/051079 patent/WO2013160701A1/en active Application Filing
- 2013-04-26 CA CA2910581A patent/CA2910581A1/en not_active Abandoned
- 2013-04-26 AU AU2013254450A patent/AU2013254450A1/en not_active Abandoned
- 2013-04-26 US US14/397,254 patent/US9610365B2/en not_active Expired - Fee Related
- 2013-04-26 CN CN201380034334.4A patent/CN104428290B/zh not_active Expired - Fee Related
- 2013-04-26 HK HK15109782.6A patent/HK1209112A1/xx unknown
- 2013-04-26 GB GB1420937.3A patent/GB2517345A/en not_active Withdrawn
- 2013-04-26 IN IN9830DEN2014 patent/IN2014DN09830A/en unknown
-
2017
- 2017-02-28 US US15/445,710 patent/US9937272B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN104428290B (zh) | 2017-11-14 |
AU2013254450A1 (en) | 2014-11-27 |
US20170266321A1 (en) | 2017-09-21 |
EP2855439B1 (en) | 2017-06-14 |
CN104428290A (zh) | 2015-03-18 |
US9937272B2 (en) | 2018-04-10 |
EP2855439A1 (en) | 2015-04-08 |
GB201420937D0 (en) | 2015-01-07 |
WO2013160701A1 (en) | 2013-10-31 |
GB2517345A (en) | 2015-02-18 |
HK1209112A1 (en) | 2016-03-24 |
US20150147275A1 (en) | 2015-05-28 |
US9610365B2 (en) | 2017-04-04 |
CA2910581A1 (en) | 2013-10-31 |
GB201207392D0 (en) | 2012-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201591064A1 (ru) | Новые производные пиридина | |
MY156938A (en) | Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application | |
WO2014062720A3 (en) | Methods of treating cancer | |
PH12014502169A1 (en) | N-cyclylamides as nematicides | |
IN2014DN09830A (enrdf_load_stackoverflow) | ||
EA201591527A1 (ru) | Новые производные пиридина | |
HK1199100A1 (en) | Methods and compositions for the treatment and diagnosis of colorectal cancer | |
WO2013089882A3 (en) | Recurrent gene fusions in breast cancer | |
WO2012158780A3 (en) | Lung cancer signature | |
WO2015077635A8 (en) | Macromolecular antioxidants based on dual type moiety per molecule: structures methods of making and using the same | |
WO2011009539A8 (de) | ε-POLYLYSIN-KONJUGATE UND DEREN VERWENDUNG | |
WO2014086982A3 (en) | Stable metal compounds, their compositions and methods of their use | |
GEP20156318B (en) | Heteroaryl derivatives as alpha7 nachr modulators | |
MX388850B (es) | Derivados de heteroarilpiperidina y de heteroarilpiperazina como fungicidas. | |
NZ597570A (en) | N1-acyl-5-fluoropyrimidinone derivatives | |
WO2013103301A3 (en) | Method for preparing cell targeting conjugates, and the complexes obtained | |
NI201100149A (es) | Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia. | |
EA201070009A1 (ru) | Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии | |
MX349373B (es) | Nuevos derivados de pirazina. | |
MX342947B (es) | Tratamiento de diabetes tipo 2. | |
WO2014039533A3 (en) | Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin | |
HK1214128A1 (zh) | 癌症的治療 | |
MX2012010127A (es) | Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos. | |
TR201903918T4 (tr) | Bir dağıtım ajanı içeren bileşimler ve bunların hazırlanması. | |
MX356126B (es) | Uso de estabilizadores de glutamina. |